MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1634.75%
Quick Ratio
1634.75%
Cash Ratio
46.16%
Debt to Asset Ratio
7.91%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Current portion of deferred reve...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
27,768
51,828
52,334
48,389
Accounts receivable, net
149
35,000
-
-
Short-term investments
943,145
904,558
914,233
940,604
Prepaid expenses and other current assets
12,275
10,663
9,320
9,093
Total current assets
983,337
1,002,049
975,887
998,086
Restricted cash
816
816
816
816
Total property and equipment
11,075
10,898
10,819
10,813
Less accumulated depreciation
7,815
7,352
6,967
6,499
Property and equipment, net
3,260
3,546
3,852
4,314
Operating lease right-of-use assets
17,327
17,870
18,402
18,923
Other long-term assets
2,913
3,944
2,608
2,627
Total assets
1,007,653
1,028,225
1,001,565
1,024,766
Accounts payable
3,017
3,376
4,971
3,395
Accrued expenses
19,513
15,476
17,633
22,156
Current portion of deferred revenue
35,070
37,591
-
-
Current portion of operating lease liabilities
2,552
2,472
2,393
2,280
Total current liabilities
60,152
58,915
24,997
27,831
Deferred revenue, net of current portion
1,079
8,676
-
-
Operating lease liabilities, net of current portion
18,438
19,099
19,746
20,380
Total liabilities
79,669
86,690
44,743
48,211
Common stock, 0.001 par value authorized shares - 200,000,000 at june 30, 2026 and december 31, 2025 issued and outstanding shares - 61,077,980 and 60,384,283 at june 30, 2026 and december 31, 2025, respectively
61
60
60
60
Additional paid-in capital
1,327,943
1,316,642
1,303,828
1,291,369
Accumulated other comprehensive income (loss)
-2,305
576
4,316
4,562
Accumulated deficit
-397,715
-375,743
-351,382
-319,436
Total stockholders' equity
927,984
941,535
956,822
976,555
Total liabilities and stockholders' equity
1,007,653
1,028,225
1,001,565
1,024,766
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$943,145K (-0.04%↓ Y/Y)Cash and cashequivalents$27,768K (-47.05%↓ Y/Y)Prepaid expenses andother current assets$12,275K (28.64%↑ Y/Y)Accounts receivable, net$149K Total property andequipment$11,075K (3.50%↑ Y/Y)Total current assets$983,337K (-2.21%↓ Y/Y)Operating leaseright-of-use assets$17,327K (-6.15%↓ Y/Y)Property and equipment,net$3,260K (-30.46%↓ Y/Y)Other long-termassets$2,913K (8.17%↑ Y/Y)Restricted cash$816K (0.00%↑ Y/Y)Less accumulateddepreciation$7,815K (29.99%↑ Y/Y)Total assets$1,007,653K (-2.38%↓ Y/Y)Total liabilities andstockholders' equity$1,007,653K (-2.38%↓ Y/Y)Total stockholders'equity$927,984K (-6.31%↓ Y/Y)Total liabilities$79,669K (91.07%↑ Y/Y)Accumulated deficit-$397,715K (-34.76%↓ Y/Y)Accumulated othercomprehensive income (loss)-$2,305K (-161.52%↓ Y/Y)Additional paid-in capital$1,327,943K (3.60%↑ Y/Y)Total currentliabilities$60,152K (181.36%↑ Y/Y)Operating leaseliabilities, net of current...$18,438K (-9.25%↓ Y/Y)Deferred revenue, net ofcurrent portion$1,079K Common stock, 0.001 parvalue authorized...$61K (3.39%↑ Y/Y)Current portion ofdeferred revenue$35,070K Accrued expenses$19,513K (21.74%↑ Y/Y)Accounts payable$3,017K (-13.23%↓ Y/Y)Current portion ofoperating lease...$2,552K (36.25%↑ Y/Y)

Janux Therapeutics, Inc. (JANX)

Janux Therapeutics, Inc. (JANX)